Upload Avatar (500 x 500)
Xinghuai Sun
xhsun@shmu.edu.cn
English, Chinese
Shanghai
Fudan University
Brain Science Research Institute
  • 1984 - Graduated from Shanghai First Medical College
  • 1990 - Received Doctor of Medicine degree
  • Chief Scientist of Major R&D Programs of the Ministry of Science and Technology
  • Recipient of the National Science and Technology Progress Award (Second Prize)
  • Recipient of the Shanghai Science and Technology Progress Award (First Prize)
  • Current - Director of the Department of Glaucoma and Optic Nerve Diseases, Eye and ENT Hospital of Fudan University
  • Current - Director of the Department of Ophthalmology and Visual Science, Shanghai Medical College of Fudan University
  • Current - Governor of the World Glaucoma Association Board
  • Current - Fellow, Academy of Asia-Pacific Professors of Ophthalmology
  • Current - Adjunct Scientist, Harvard Medical School Eye and Ear Hospital
  • Current - Honorary Professor, Department of Ophthalmology and Visual Sciences, Chinese University of Hong Kong
  • National Science and Technology Progress Award (Second Prize)
  • Shanghai Science and Technology Progress Award (First Prize)
  • Outstanding Young and Middle-aged Expert with Outstanding Contributions, Ministry of Health
  • Shanghai Science and Technology Elite
  • Shanghai Outstanding Research Institute Director Award
  • Asia-Pacific Academy of Ophthalmology (APAO) Outstanding Contribution Award
  • Chinese Ophthalmology Outstanding Achievement Award
Glaucoma neurodegeneration and protection mechanisms
Visual plasticity and reconstruction in low vision
  • Nicotinamide ameliorates energy deficiency and improves retinal function in Cav-1-/- mice., Tang Y, Fang W, Xiao Z, Song M, Zhuang D, Han B, Wu J, Sun X, 2020
  • Activated ephrinA3/EphA4 forward signaling induces retinal ganglion cell apoptosis in experimental glaucoma., Xu LJ, Gao F, Cheng S, Zhou ZX, Li F, Miao Y, Niu WR, Yuan F, Sun XH, Wang Z, 2020
  • Circular RNA-ZNF609 regulates retinal neurodegeneration by acting as miR-615 sponge., Wang JJ, Liu C, Shan K, Liu BH, Li XM, Zhang SJ, Zhou RM, Dong R, Yan B, Sun XH, 2018
  • Primary angle closure glaucoma: What we know and what we don't know., Sun X, Dai Y, Chen Y, Yu DY, Cringle SJ, Chen J, Kong X, Wang X, Jiang C, 2017
  • Sustained Release of Brimonidine from a New Composite Drug Delivery System for Treatment of Glaucoma., Sun J, Lei Y, Dai Z, Liu X, Huang T, Wu J, Xu ZP, Sun XH, 2017
Glaucoma Neurodegeneration Protection Mechanisms Visual Plasticity Reconstruction Low Vision Neuroscience Ophthalmology

Contact us

Let's talk!
* Required
* Required
* Required
* Invalid email address
By submitting this form, you agree that IoT ONE may contact you with insights and marketing messaging.
No thanks, I don't want to receive any marketing emails from IoT ONE.
Submit

Thank you for your message!
We will contact you soon.